ArticleFrontiers in medicine2026
Efficacy of major ozone autohemotherapy in patients with post-COVID syndrome.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effects of Oxygen-Ozone Therapy and Physiotherapy on Functioning in Patients with Chronic Non-Specific Neck Pain: A Prospective Double-Arm Pilot Study.Journal of functional morphology and kinesiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objectives: It has been suggested that medical ozone treatment may be used for post-COVID syndrome, but there is still a lack of evidence. The aim of the study is to investigate the efficacy of medical ozone treatment in fatigue, anxiety, depression, quality of life, and quality of sleep in patients diagnosed with post-COVID syndrome. Materials and methods: The study was designed as a retrospective medical records review study. It was conducted at Baskent University in patients who had been diagnosed with post-COVID syndrome and accepted 10 sessions of major ozone autohemotherapy. Demographic data, FACIT Fatigue Scale, Beck Depression Inventory, Beck Anxiety Inventory, Pittsburgh Sleep Quality Index, and Short Form-36 scores were obtained from the hospital database. The scores before and after treatment were compared statistically. Results: A total of 40 patients were analyzed. Thirty two of them were female, and eight of them were male. It was determined that both Beck Anxiety Inventory and Beck Depression Inventory scores were decreased after ozone application ( Conclusion: The patients suffering from post-COVID syndrome may benefit from major blood ozonation. The treatment may be one of the complementary treatments after COVID-19 infection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.